City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
Click here to login to Secure Web Site   (authorized users only)  
  
Search results:  46  Clinical trial(s) found  (Page 1 of 2 )
Results per page: 25 50 100 All 1-25 Trials Jump to page:

The following studies are available for Brain and Nervous System Cancer:
COH Protocol Number: 13418 ClinicalTrials.gov Number: NCT02014844

Principal Investigator: Jana Portnow, MD
Sponsor: Industrial

Title:  An Open-Label Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of Aldoxorubicin in Subjects with Unresectable Glioblastoma Whose Tumors Have Progressed Following Prior Treatment with Surgery, Radiation and Temozolomide

COH Protocol Number: 13276 ClinicalTrials.gov Number: NCT01798004

Principal Investigator: Anna Pawlowska, MD
Sponsor: Cooperative Group

Title:  COG ANBL12P1: Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma

COH Protocol Number: 13162 ClinicalTrials.gov Number: NCT01553149

Principal Investigator: Anna Pawlowska, MD
Sponsor: Cooperative Group

Title:  COG ACNS1022: A Phase II Randomized Trial of Lenalidomide (NSC #703813, IND #70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas

COH Protocol Number: 13140 ClinicalTrials.gov Number: NCT01096368

Principal Investigator: Anna Pawlowska, MD
Sponsor: Cooperative Group

Title:  COG ACNS0831:Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma ages 1-21 years

COH Protocol Number: 13123 ClinicalTrials.gov Number: NCT00916409

Principal Investigator: Jana Portnow, MD
Sponsor: Industrial

Title:  A Prospective, Multi-Center Trial of NovoTTF-100A Together with Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM

COH Protocol Number: 13116 ClinicalTrials.gov Number: NCT01156584

Principal Investigator: Jana Portnow, MD
Sponsor: Industrial

Title:  A Phase I Ascending Dose Trial of the Safety and Tolerability of Toca 511 in Patients with Recurrent High Grade Glioma

COH Protocol Number: 12242

Principal Investigator: Jana Portnow, MD
Sponsor: Institutional

Title:  An Intracerebral Microdialysis Study in Patients with Recurrent High Grade Gliomas Being Treated with TOCA 511 and TOCA FC

COH Protocol Number: 11320 ClinicalTrials.gov Number: NCT01627535

Principal Investigator: Neal Prakash, MD, PhD
Sponsor: Institutional

Title:  Feasibility of Intraoperative Optical Imaging and Spectroscopy in Brain Tumors

COH Protocol Number: 11216 ClinicalTrials.gov Number: NCT01480479

Principal Investigator: Jana Portnow, MD
Sponsor: Industrial

Title:  An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma (The "ACT IV" Study)

COH Protocol Number: 11180 ClinicalTrials.gov Number: NCT00045968

Principal Investigator: Jana Portnow, MD
Sponsor: Industrial

Title:  A Phase III Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme

COH Protocol Number: 08138

Principal Investigator: Ellie Maghami, MD
Sponsor: Institutional

Title:  City of Hope Head and Neck Database Using the American Head and Neck Society Otobase

COH Protocol Number: 07185

Principal Investigator: Smita Bhatia, MD
Sponsor: NCI Approved External Peer Review

Title:  Childhood Cancer Survivor Study

COH Protocol Number: 02079 ClinicalTrials.gov Number: NCT00026312

Principal Investigator: Anna Pawlowska, MD
Sponsor: Cooperative Group

Title:  COG ANBL0032: Phase III Randomized Study Of Chimeric Antibody 14.18 (CH14.18) In High Risk Neuroblastoma Following Myeloablative Therapy And Autologous Stem Cell Rescue

COH Protocol Number: 01094

Principal Investigator: Anna Pawlowska, MD
Sponsor: Cooperative Group

Title:  COG ANBL00B1: Neuroblastoma Biology Studies

The following studies are available for many cancer types, including Brain and Nervous System Cancer:
COH Protocol Number: 13385 ClinicalTrials.gov Number: NCT02077218

Principal Investigator: Saro Armenian, DO
Sponsor: Institutional

Title:  Assessment of Coronary Artery Disease in Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT): A Pilot Feasibility Study

COH Protocol Number: 13372

Principal Investigator: Sanjeet Dadwal, MD
Sponsor: Industrial

Title:  Emergency Use of DAS181-F02 (Fludase) in a Second Immunocompromised Subject with Parainfluenza (PIV) Infection

COH Protocol Number: 13331 ClinicalTrials.gov Number: NCT01907802

Principal Investigator: Vincent Chung, MD
Sponsor: NCI Approved External Peer Review

Title:  PHI-73, NCI # 9343: A Phase 1 and Pharmacokinetic Study of Dabrafenib (GSK2118436B) in Patients with BRAF V600X Mutations and Renal or Hepatic Dysfunction

COH Protocol Number: 13275

Principal Investigator: Anna Pawlowska, MD
Sponsor: Non-NCI Approved External Peer Review

Title:  Predictive Biomarkers For Pediatric Chronic Graft-Versus­-Host Disease

COH Protocol Number: 13242 ClinicalTrials.gov Number: NCT01877811

Principal Investigator: Marwan Fakih, MD
Sponsor: Industrial

Title:  An Open-Label, Phase 1/Phase 2, Single-Agent Study of CEP-32496 in Patients with Advanced Solid Tumors in Phase 1 and in Patients with Advanced Melanoma and Metastatic Colorectal Cancer with BRAF Mutation in Phase 2

COH Protocol Number: 13238

Principal Investigator: Jeffrey Wong, MD
Sponsor: Industrial

Title:  A Post Approval Registry: ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain

COH Protocol Number: 13237 ClinicalTrials.gov Number: NCT01833806

Principal Investigator: Jeffrey Wong, MD
Sponsor: Industrial

Title:  A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain

COH Protocol Number: 13128 ClinicalTrials.gov Number: NCT01817335

Principal Investigator: Jeanelle Folbrecht, Ph.D
Sponsor: Institutional

Title:  Pilot Study of Psycho-Educational Group for Young Adults (YA) on Treatment: Impact on Knowledge, Distress, and Satisfaction

COH Protocol Number: 13103 ClinicalTrials.gov Number: NCT02041416

Principal Investigator: Arti Hurria, MD
Sponsor: NCI Approved External Peer Review

Title:  Delivering the Geriatric Assessment Tool to Older Adults with Cancer Using Computer Survey Methodologies: Testing Feasibility, Reliability, and Validity of Research Electronic Data Capture (REDCap) and Support Screen (Touchscreen) Technologies

COH Protocol Number: 12386

Principal Investigator: Gagandeep Singh, MD
Sponsor: Institutional

Title:  The Use of Irreversible Electroporation (IRE) in Operative Ablation of Solid Cancer: A Registry Study

COH Protocol Number: 12302

Principal Investigator: Smita Bhatia, MD
Sponsor: NCI Approved External Peer Review

Title:  Blood or Marrow Transplant Long-term Follow-up Study - 2

 
Results per page: 25 50 100 All 1-25 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.